Tower Research Capital LLC (Trc) Dare Bioscience, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $0.61 $1,400 - $3,051	-5,002 Reduced 24.64%	15,302 $5,000
Q1 2024 May 15, 2024	SELL	$0.31 - $0.57 $1,618 - $2,975	-5,220 Reduced 20.45%	20,304 $9,000
Q4 2023 Feb 13, 2024	BUY	$0.29 - $0.53 $1,477 - $2,700	5,095 Added 24.94%	25,524 $7,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.91 $4,858 - $9,612	10,563 Added 107.06%	20,429 $9,000
Q2 2023 Aug 14, 2023	SELL	$0.91 - $1.05 $6,387 - $7,369	-7,019 Reduced 41.57%	9,866 $8,000
Q1 2023 May 09, 2023	BUY	$0.87 - $1.36 $1,493 - $2,335	1,717 Added 11.32%	16,885 $17,000
Q4 2022 Feb 10, 2023	SELL	$0.82 - $12.6 $8,014 - $123,152	-9,774 Reduced 39.19%	15,168 $13,000
Q3 2022 Nov 10, 2022	BUY	$1.04 - $12.48 $300 - $3,606	289 Added 1.17%	24,942 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.76 $16,276 - $30,474	-17,315 Reduced 41.26%	24,653 $30,000
Q1 2022 May 12, 2022	BUY	$1.42 - $2.09 $59,594 - $87,713	41,968 New	41,968 $62,000
Q4 2021 Feb 14, 2022	SELL	$1.42 - $2.13 $105,423 - $158,135	-74,242 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.42 - $2.0 $103,921 - $146,368	73,184 Added 6917.2%	74,242 $124,000
Q2 2021 Aug 16, 2021	SELL	$1.21 - $1.89 $1,621 - $2,532	-1,340 Reduced 55.88%	1,058 $2,000
Q1 2021 May 17, 2021	SELL	$1.31 - $3.0 $3,112 - $7,128	-2,376 Reduced 49.77%	2,398 $4,000
Q4 2020 Feb 16, 2021	SELL	$0.96 - $1.51 $7,154 - $11,254	-7,453 Reduced 60.96%	4,774 $6,000
Q3 2020 Nov 16, 2020	SELL	$0.98 - $1.52 $1,169 - $1,813	-1,193 Reduced 8.89%	12,227 $12,000
Q2 2020 Aug 13, 2020	BUY	$0.84 - $1.11 $11,272 - $14,896	13,420 New	13,420 $13,000

Others Institutions Holding DARE

# of Institutions

Shares Held

267K

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account